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Background.Central venous catheters and peripherally inserted central catheters arewell established risk factors for upper limbdeep
vein thrombosis.There is limited literature on the thrombosis rates in patientswith peripheral catheters. Aprospective observational
study was conducted to determine the incidence of peripheral catheter-related thrombosis in surgical patients. Methods. Patients
deemed high risk for venous thrombosis with a peripheral catheter were considered eligible for the study. An ultrasound was
performed on enrolment into the study and at discharge from hospital. Participants were reviewed twice a day for clinical features
of upper limb deep vein thrombosis during their admission and followed up at 30 days. Results. 54 patients were included in the
study.The incidence of deep vein thrombosis and superficial venous thrombosis was 1.8% and 9.2%, respectively. All cases of venous
thrombosis were asymptomatic. Risk factor analysis was limited by the low incidence of thrombosis.Conclusion.This study revealed
a low incidence of deep vein thrombosis in surgical patientswith peripheral catheters (1.8%).The studywas underpowered; therefore
the association between peripheral catheters and thrombosis is unable to be established. Future studies with larger sample sizes are
required to determine the association between peripheral catheters and thrombosis.
1. Introduction
Upper limb deep vein thrombosis (DVT) refers to the
formation of a fibrin clot within the subclavian, axillary, and
brachial veins of the arm [1]. The vast majority of cases of
upper limb DVT are associated with the use of indwelling
intravenous catheters [2].While any intravenous catheter has
the potential to lead to venous thrombosis, the literature has
mainly focused on the thrombosis rates of central venous
catheters (CVCs) and peripherally inserted central catheters
(PICCs) [3]. Over 330 million peripheral catheters are placed
every year inAmerica alone, required by up to 70%of patients
in hospital. Peripheral catheters are often used in surgical
patients for the administration of intravenous fluids and
intravenous medications and for anaesthetic purposes [4].
Although the insertion of a peripheral catheter is the most
common invasive procedure in hospitals, there is a paucity
of data regarding thrombosis rates in patients with periph-
eral catheters. As many surgical patients require a periph-
eral catheter during their admission, we have conducted
a prospective study to detect the incidence of peripheral
catheter-related DVT in the general surgical unit and the
potential associated risk factors. A secondary aim was to
determine the incidence of catheter-related superficial vein
thrombosis (SVT).
2. Methods
2.1. Eligible Patients. All patients hospitalized in the general
surgical unit classified as high risk for venous thromboem-
bolism (VTE) with a peripheral intravenous catheter in the
dorsal hand or forearm were considered for inclusion. We
accepted peripheral intravenous catheters of any gauge. We
defined high risk as age over 65 years and one other risk factor
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either an underlying malignancy, thrombophilia (Factor C
deficiency, Factor S deficiency, Factor 5 Leiden mutation,
antithrombin 3 deficiency, antiphospholipid syndrome, and
prothrombin 20210A mutation), or recent major surgery
according to criteria from the Royal Australasian College of
Surgeons (RACS) [5]. Exclusion criteria included previous
or current upper limb or chest trauma, previous or current
upper limb, neck, or axillary surgery, previous or current
upper limb DVT, previous mastectomy, thoracic outlet syn-
drome, enlarged lymph nodes/tumours causing compression,
or current central venous catheter or peripherally inserted
central catheter. Participants were prospectively followed up
for 30 days from enrolment.
2.2. Study Design. The study was a prospective observational
single arm cohort study conducted in the general surgical
unit of Mackay Base Hospital. The study period occurred
from August 2014 to July 2015. The study received ethical
approval from the Townsville Hospital and Health Services
Human Resources and Ethics Committee on the 30th of
May 2014. Informed consent was obtained from all indi-
vidual participants included in the study. On enrolment,
the participant’s demographics, medical comorbidities, full
blood count, international normalised ratio of prothrombin
time of blood coagulation (INR), and catheter characteristics
were collected. All patients had an ultrasound examination
of the superficial and deep veins of the cannulated arm on
enrolment into the study and at discharge. Colour duplex
sonography was selected for diagnosis of DVT as it has a high
sensitivity (93%) and specificity (93%) and is noninvasive
and easy to perform [6]. All ultrasounds were performed
by the sonographers at the Mackay Base Hospital Radiology
Department. The criteria for upper extremity thrombosis
were defined as the presence of a thrombus, lack of flow,
nonpulsatile and nonphasic flow, and lack of compressibility
of the veins [7]. DVT was classified as thrombosis of the
subclavian, axillary, or brachial veins. Thrombosis of the
cephalic or basilic vein was classified as a SVT. During the
admission period, patients were reviewed twice a day for
signs and symptoms of upper limb DVT. Patients were asked
if they had experienced upper limb pain and swelling. On
examination, abnormal vital signs, tenderness, oedema, and
erythema of the cannulated arm were noted. All patients
were followed up at thirty days with either a phone consult
or outpatient appointment to review symptoms of venous
thromboembolism (VTE).
2.3. Statistical Analysis. The incidence of peripheral catheter-
related DVT has only been reported in one previous study.
Therefore we estimated a 20% prevalence based on the
results of this study. Based on the estimated prevalence, we
calculated a sample size of 62 participants for 95%Confidence
Intervals (CI) of 10% to 30%. The incidence of peripheral
catheter-related thrombosis is reported as the proportion of
enrolled patients who had an ultrasound confirmed throm-
bus. Corresponding 95% CIs were calculated for the pro-
portions of thrombosis. Descriptive statistics were generated
for all included cases. Continuous variables were expressed
as medians and interquartile ranges (IQR 25th and 75th
percentile) or means and standard deviations (SD). The cate-
gorical variables were expressed as numbers and percentages.
Bivariate analysis was performed using Fisher’s exact test with
thrombosis as the dependent variable and various risk factors
as the independent variable. The data was analysed using
SPSS version 20 (SPSS Inc., Chicago, IL, USA) for Windows;
statistical significance was given to 𝑃 values < 0.05.
3. Results
From August 2014 to July 2015 there were 337 participants
aged 65 years and over who had a peripheral catheter placed
in the dorsal hand or forearm in the general surgical unit.
Two-hundred and sixty patients did not meet eligibility crite-
ria and 17 declined to enter the study. Sixty patients consented
to participate in the study. Six patients did not complete the
study. Five patients were lost to follow-up and one patient
passed away from an underlyingmedical condition unrelated
to the study. In total, data from 54 patients was analysed. The
participant characteristics are listed in Table 1. None of the
recruited participants had a thrombophilia. The incidence of
upper limb DVTwas 1.8% (1 out of 54 patients, 95% CI −1.7%
to 5.4%). The thrombus was located in the brachial vein. The
only risk factors the patient had were age over 65 years and
recent surgery.The patient was commenced on six months of
warfarin as per the physicians at Mackay Base Hospital. The
incidence of SVTwas 9.25% (5 out of 54 patients, 95%CI 1.5%
to 17%). Four were located in the cephalic vein and one in the
basilic vein. All patients with SVT were treated with 30 days
of therapeutic low molecular weight heparin (LMWH) as
per the American College of Chest Physician Guidelines for
antithrombotic therapy for venous thromboembolic disease
[8]. The characteristics of the participants with peripheral
catheter-related venous thrombosis is displayed in Table 2.
The overall incidence of thrombotic events was 11.1% (95%
CI 2.7% to 19.5%). All cases of venous thrombosis were
asymptomatic. There were no cases of clinically detected
pulmonary embolism. None of the risk factors investigated
were found to be statistically significant for association with
upper extremity thrombosis, as listed inTable 3. At the 30-day
follow-up there were no reported adverse events.
4. Discussion
Ours is the first prospective study designed to detect the
incidence of peripheral catheter-related DVT and to identify
associated risk factors in surgical patients. We detected a
low incidence of peripheral catheter-DVT (incidence of 1.8%)
with no associated risk factors. However there was a higher
incidence of peripheral catheter-related SVT (9.8%). All cases
of peripheral catheter-related thrombosis in our study were
asymptomatic and detected on ultrasound as a result of our
study. There were no cases of pulmonary embolism clinically
detected in our study.
The low incidence of peripheral catheter-related DVT
reinforces the results of a previous study. A randomised
control trial comparing the efficacy of PICCS and peripheral
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Table 1: Characteristics of the participants.
Variable Result
Age (years), median (IQR) 73 (69–79.25)
Gender, 𝑛 (%) female 21 (38.9%)
Ethnicity, 𝑛 (%)
Caucasian 53 (98.1%)
Aboriginal and Torres Strait Islander 1 (1.98%)
Anticoagulation, 𝑛 (%) 25 (46.3%)
Haemaglobin, median (IQR) 130 (121.75–142.25)
Platelets, median (IQR) 226 (177–316.5)
INR, median (IQR) 1.1 (1.0–1.1)
Catheter size, 𝑛 (%)
18G 48 (88.9%)
20G 3 (5.6%)
22G 3 (5.6%)
Time of catheterization in days,
median (IQR) 3.83 (2–5)
Location of peripheral catheter, 𝑛 (%)
Dorsum hand 17 (31.5%)
Wrist 6 (11.1%)
Forearm 10 (18.5%)
Cubital fossa 21 (38.9%)
Resited peripheral catheters, 𝑛 (%) 52 (96.3%)
Number of attempts at catheterization,
mean (SD) 1 (0.79)
BMI, 𝑛 (%) 17 (31.5%)
Diabetes, 𝑛 (%) 15 (27.8%)
Malignancy, 𝑛 (%) 20 (37%)
Metastatic disease, 𝑛 (%) 3 (5.6%)
Recent surgery, 𝑛 (%) 40 (74.1%)
catheters found a 3.4% incidence of peripheral catheter-
related DVT. Similar to our study ultrasound was performed
at the beginning and end of catheterization. There was a
higher incidence of peripheral catheter-related SVT than the
incidence of peripheral catheter-related DVT in our study.
The incidence of peripheral catheter-related SVT was lower
than figures reported in a previous study (9.2% compared
to 44%). The increased incidence of SVT in Periard’s study
is likely attributed to larger gauge of catheters used and
increased time of catheterization [9]. The thrombogenicity
of peripheral catheters can be attributed to endothelial injury
and venous stasis, two of the components of Virchow’s triad
of thrombosis. The endothelium is often damaged during
the insertion of a peripheral catheter [3]. In addition, the
presence of a peripheral catheter in a vein reduces blood flow
and potentially causes venous stasis. Peripheral catheters are
often inserted into the smaller superficial veins of the upper
limb creating a smaller catheter-to-vein ratio. Catheter-to-
vein ratio has been suggested to be a contributing factor to
thrombosis due to increased risk of stasis from a slower flow.
This is evident in studies with PICC-lines as PICCs inserted
into the smaller cephalic veins are more likely to thrombose
[10].
We assessed recent surgery, malignancy, metastatic dis-
ease, increased BMI, diabetes mellitus, cannula gauge, num-
ber of attempts at cannulation, and length of catheterization
for association with catheter-related thrombosis. None of
the risk factors assessed in our study were found to have
a significant association with catheter-related thrombosis.
However, the data analysis was limited by the small number
of events. In our study 83% of participants with upper
extremity thrombosis had recent surgery. Previous studies
report mixed results regarding recent surgery as a risk
factor for catheter-related thrombosis [11–15]. Wilson et al.
demonstrated that surgery >1 hour in length was a risk factor
for catheter-related thrombosis in a prospective study. The
development of a thrombus was attributed to venous stasis
from prolonged paresis of the arm during surgery [15]. Half
of the patients with a peripheral catheter-related thrombosis
had a malignancy. The association between malignancy and
venous thrombosis has been well established. Malignancy is
believed to induce a hypercoagulable state through activation
of the coagulation cascade and generation of thrombin [11].
The results of our study raise questions regarding screen-
ing for asymptomatic upper extremity thrombosis. None of
the patients with peripheral catheter-related thrombosis were
symptomatic. Previous studies have reported similar findings
where all cases of thrombosis were found incidentally on
ultrasound [9]. These results confirm the need for imaging
in the diagnosis of peripheral catheter-related thrombosis as
most cases are asymptomatic.
There are strong arguments in literature regarding anti-
coagulation of symptomatic upper limb DVT as it prevents
propagation of the thrombus and development of a pul-
monary embolism (PE) [9]. The clinical significance of an
asymptomatic upper limb DVT is poorly documented as the
majority of studies are conducted on symptomatic patients
[16]. As the nature of asymptomatic upper limb DVT is
unknown, the risks and benefits of treatment are unknown.
Theoretically the risk of embolization of the asymptomatic
thrombus should be the same as a symptomatic upper limb
DVT. In fact, asymptomatic DVT of the lower limb has long
been regarded as a source of embolization. In a large autopsy
series lower limb DVT was detected in 83% of patients who
died from PE; however only 19% were symptomatic [17].
The findings of the study suggest that asymptomatic upper
limb DVT may be an overlooked source of PE. However
large randomised studies would be required to determine the
clinical significance of an asymptomatic upper limb DVT.
We detected five cases of SVT in our study. SVT has
previously been regarded as a benign disease; however there
is a growing body of evidence to suggest otherwise [18, 19].
Decousus et al. demonstrated that 25% of patients with
a lower limb superficial venous thrombosis developed a
concomitant deep vein thrombosis and 3.9% had a symp-
tomatic pulmonary embolism [20]. While there are currently
no studies regarding the clinical significance of an upper
extremity DVT, based on the studies conducted on the lower
limb we decided to treat patients diagnosed with SVT with
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Table 3: Risk factors.
Risk factor Number of thromboses 𝑃 value
Gender (female) 4/21 (19%) 0.193
Ethnicity (Caucasian) 6/53 (11.3%) 1
Diabetes 1/15 (6.66%) 1
Metastatic disease 0/3 (0%) 1
Anticoagulation 3/25 (12%) 1
Elevated WCC 1/8 (12.5%) 1
BMI >30 2/17 (11.76%) 1
Cannula LOS >1 NS
Size of cannula NS
Cubital fossa 4/21 (19%) NS
More than 1 attempt 1/12 (8.33%) NS
Malignancy 3/20 (15%) 0.659
Surgery 4/40 (10%) 0.643
30 days of LMWH. At the 30-day follow-up there were no
adverse events or complications reported.
There were no cases of clinically detected PE in our study.
Similar findings have been reported in previous studies.
In a large retrospective series, Chemaly et al. reported an
incidence of 3.4% of PE in patients with PICC-lines [21].
The incidence of asymptomatic PE is higher in patients with
catheter-related thrombosis, with up to 17% of patients with
catheter-related thrombosis having an asymptomatic PE [22].
However the mortality rate associated with asymptomatic
PE appears to be low. It is uncertain whether investigation
of asymptomatic PE would be of benefit considering the
invasiveness of the investigations required [23].
There are several limitations to our study. The present
study is a prospective observational study conducted in a
single regional institution; therefore the findings of this study
may not be applicable to other hospital populations. There
is inherent bias associated with the observational design of
the study as confounders are unable to be controlled and
there are a lack of internal controls. The study was under-
powered; therefore the confidence intervals are very broad,
indicating that the results are imprecise.The low incidence of
peripheral catheter-related thrombosis limited the ability to
identify associated risk factors. Nonconsecutive patients were
enrolled into the study; therefore the study sample may not
be a true reflection of the intended sample. Ideally, both arms
would be scanned for a DVT; however this would have been
too difficult considering financial constraints of the study.
Furthermore patients were only followed up for 30 days;
therefore symptoms of upper limb DVT after 30 days are
unknown.
Despite the limitations, there were also several strengths
with this study. This is the first study to investigate the
incidence of peripheral catheter-related venous thrombosis
in surgical patients. The prospective design and investiga-
tion of all study participants prevented missing any case
of peripheral catheter-related thrombosis. In addition this
confirmed the asymptomatic nature of peripheral catheter-
related thrombosis. We also used objective investigations to
diagnose thrombosis preventing misdiagnosis. This is also
the first study to investigate the risk factors for upper limb
superficial venous thrombosis.
5. Conclusion
In our study we recorded a low incidence of peripheral
catheter-related DVT (1.8%, 95% CI −1.7% to 5.4%), but a
higher incidence of superficial venous thrombosis (9.25%,
95%CI 1.5% to 17%).The small sample size and low incidence
of peripheral catheter-related thrombosis limited our ability
to determine the association between peripheral catheters
and upper limb DVT. Future studies will be required to show
the natural history of an asymptomatic upper limb DVT
through regular ultrasounds and investigation for occult
pulmonary emboli.
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